207 results
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
before our filing date or the other party benefits from a compulsory license. However, the Leahy-Smith Act and its implementation could increase … and benefits noted throughout this report.
The reshoring and protection of the domestic biotech ecosystem – GeoVax represents the first domestic source
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
or the other party benefits from a compulsory license. However, the Leahy-Smith Act and its implementation could increase the uncertainties and costs … performing Covid vaccines – GeoVax’s MVA-vectored Covid-19 vaccine candidates (e.g., GEO-CM04S1) is a logical candidate given the features and benefits noted
POS AM
optbylk0efdpu6
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
POS AM
wk2z20eiyp
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
424B3
7ftq50dt7nw96
12 Jan 24
Prospectus supplement
4:00pm
8-K
EX-4.1
lrbjw4x xsqsv
4 Dec 23
Entry into a Material Definitive Agreement
8:00am
S-8
EX-99.1
y3y0xy
22 Aug 23
Registration of securities for employees
4:06pm
S-8
EX-99.2
2zrfzc3771gmhwcfkon
22 Aug 23
Registration of securities for employees
4:06pm
8-K
EX-10.1
2ytvol0p9hqos 7vqe
18 Jul 23
Entry into a Material Definitive Agreement
4:27pm
424B5
qnct9 0pupbrt
18 Jul 23
Prospectus supplement for primary offering
4:13pm